Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J. Nutt

Showing results (51-60 of 329) with videos related to

Pageof 33
Sort By:
Neuropharmacology|December 29, 2017
Psychiatry & the psychedelic drugs. Past, present & futureJames J H Rucker, Jonathan Iliff, David J Nutt
Journal of Clinical Psychopharmacology|January 25, 2003
Psychotropic drugs, cardiac arrhythmia, and sudden deathHarry J Witchel, Jules C Hancox, David J Nutt
Journal of Psychopharmacology (Oxford, England)|June 21, 2013
Lamotrigine for attention deficit-hyperactivity disorder comorbid with mood disorders: a case seriesBedriye Öncü, Okan Er, Burçin Çolak, et al.
Convulsive Therapy|January 1, 1991
Do Opioid, alpha(2)-Adrenoreceptors, or Benzodiazepine Receptors Mediate ECS-Induced Hypothermia in Mice?Helen C. Jackson, Paul J. Weinberger, David J. Nutt
European Journal of Pharmacology|January 14, 2003
Naloxone displacement at opioid receptor sites measured in vivo in the human brainJan K Melichar, David J Nutt, Andrea L Malizia
The Australian and New Zealand Journal of Psychiatry|July 6, 2005
Acute tryptophan depletion. Part II: clinical effects and implicationsCaroline J Bell, Sean D Hood, David J Nutt
Biological Psychiatry|March 10, 2009
Serotonin and sensitivity to trauma-related exposure in selective serotonin reuptake inhibitors-recovered posttraumatic stress disorderFelipe Corchs, David J Nutt, Sean Hood, et al.
International Journal of Psychiatry in Clinical Practice|June 20, 2014
NAPSAQ-1: National Patient Sleep Assessment Questionnaire in depressionLouise M Paterson, David J Nutt, Sue J Wilson
Journal of Psychopharmacology (Oxford, England)|March 24, 2016
γ-aminobutyric acid as a metabolite: Interpreting magnetic resonance spectroscopy experimentsJames Fm Myers, David J Nutt, Anne R Lingford-Hughes
British Journal of Pharmacology|December 19, 2024
The Australia story: Current status and future challenges for the clinical applications of psychedelicsDavid J Nutt, Peter Hunt, Anne Katrin Schlag, et al.
Pageof 33

Showing results (51-60 of 329) with videos related to

Sort By:
Pageof 33
Neuropharmacology|December 29, 2017
Psychiatry & the psychedelic drugs. Past, present & futureJames J H Rucker, Jonathan Iliff, David J Nutt
Journal of Clinical Psychopharmacology|January 25, 2003
Psychotropic drugs, cardiac arrhythmia, and sudden deathHarry J Witchel, Jules C Hancox, David J Nutt
Journal of Psychopharmacology (Oxford, England)|June 21, 2013
Lamotrigine for attention deficit-hyperactivity disorder comorbid with mood disorders: a case seriesBedriye Öncü, Okan Er, Burçin Çolak, et al.
Convulsive Therapy|January 1, 1991
Do Opioid, alpha(2)-Adrenoreceptors, or Benzodiazepine Receptors Mediate ECS-Induced Hypothermia in Mice?Helen C. Jackson, Paul J. Weinberger, David J. Nutt
European Journal of Pharmacology|January 14, 2003
Naloxone displacement at opioid receptor sites measured in vivo in the human brainJan K Melichar, David J Nutt, Andrea L Malizia
The Australian and New Zealand Journal of Psychiatry|July 6, 2005
Acute tryptophan depletion. Part II: clinical effects and implicationsCaroline J Bell, Sean D Hood, David J Nutt
Biological Psychiatry|March 10, 2009
Serotonin and sensitivity to trauma-related exposure in selective serotonin reuptake inhibitors-recovered posttraumatic stress disorderFelipe Corchs, David J Nutt, Sean Hood, et al.
International Journal of Psychiatry in Clinical Practice|June 20, 2014
NAPSAQ-1: National Patient Sleep Assessment Questionnaire in depressionLouise M Paterson, David J Nutt, Sue J Wilson
Journal of Psychopharmacology (Oxford, England)|March 24, 2016
γ-aminobutyric acid as a metabolite: Interpreting magnetic resonance spectroscopy experimentsJames Fm Myers, David J Nutt, Anne R Lingford-Hughes
British Journal of Pharmacology|December 19, 2024
The Australia story: Current status and future challenges for the clinical applications of psychedelicsDavid J Nutt, Peter Hunt, Anne Katrin Schlag, et al.
Pageof 33